Drugs inquiry thrown into doubt over members' links with manufacturers

"The credibility of a government inquiry intended to settle the controversy surrounding widely prescribed anti-depressant drugs was thrown into question yesterday by revelations that most of the members have shareholdings or other links to the manufacturers."